Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events
- PMID: 12149241
Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events
Abstract
There exists a wide spectrum of IgM-secreting B-cell tumors with different clinical behavior. Knowledge of the V(H) gene status can reveal their origin and clonal history. For Waldenstrom macroglobulinemia (WM), a distinct subtype of lymphoplasmacytic lymphoma, early data on limited sequences showed evidence for somatic mutation. A recent report of one case demonstrated intraclonal mutational activity occurring after transformation, a characteristic of germinal center lymphomas. To extend the investigation, we have analyzed 7 cases of WM. V(H) genes were somatically mutated with no evidence of intraclonal variation in all cases. In contrast to IgM-secreting multiple myeloma, there was no evidence for isotype switch transcripts in any of the cases. These data support the concept that typical WM is derived from a B cell that has undergone somatic mutation prior to transformation, at a point where isotype switch events have not been initiated. (Blood. 2002;100:1505-1507)
Similar articles
-
Origins of the malignant clone in typical Waldenstrom's macroglobulinemia.Semin Oncol. 2003 Apr;30(2):136-41. doi: 10.1053/sonc.2003.50072. Semin Oncol. 2003. PMID: 12720123
-
V(H) gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events.Blood. 1999 Aug 1;94(3):1070-6. Blood. 1999. PMID: 10419900
-
Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood.Blood. 2004 Oct 1;104(7):2134-42. doi: 10.1182/blood-2003-11-4024. Epub 2004 Feb 5. Blood. 2004. PMID: 14764523
-
Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor?Clin Lymphoma. 2005 Mar;5(4):217-9. doi: 10.3816/clm.2005.n.002. Clin Lymphoma. 2005. PMID: 15794851 Review.
-
Lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia: an evolving concept.Adv Anat Pathol. 2005 Sep;12(5):246-55. doi: 10.1097/01.pap.0000184176.65919.17. Adv Anat Pathol. 2005. PMID: 16210920 Review.
Cited by
-
Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis.Med Oncol. 2005;22(4):327-41. doi: 10.1385/MO:22:4:327. Med Oncol. 2005. PMID: 16260850 Review.
-
Waldenstrom macroglobulinemia.Cancer Lett. 2008 Oct 18;270(1):95-107. doi: 10.1016/j.canlet.2008.04.040. Epub 2008 Jun 13. Cancer Lett. 2008. PMID: 18555588 Free PMC article.
-
B-Cell-Specific Myd88 L252P Expression Causes a Premalignant Gammopathy Resembling IgM MGUS.Front Immunol. 2020 Dec 1;11:602868. doi: 10.3389/fimmu.2020.602868. eCollection 2020. Front Immunol. 2020. PMID: 33343574 Free PMC article.
-
Targeting BCL2 in Waldenström macroglobulinemia: from biology to treatment management.Front Oncol. 2025 Apr 22;15:1564869. doi: 10.3389/fonc.2025.1564869. eCollection 2025. Front Oncol. 2025. PMID: 40330831 Free PMC article. Review.
-
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.Blood. 2006 Oct 15;108(8):2755-63. doi: 10.1182/blood-2006-02-005488. Epub 2006 Jun 27. Blood. 2006. PMID: 16804116 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources